This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:

fact-checked

trusted source

proofread

Advancing technologies for using cells as biofactories

Advancing technologies for using cells as biofactories
Contributions from advances in the synthetic biology toolbox and strain/clone development enable cellular systems to be used as a biological-based factory spanning products within industrial biotechnology and biopharmaceutical manufacturing. Additional collaboration and innovation between these two fields can leverage similarities to achieve ambitious goals in biochemical production. Credit: Industrial Biotechnology (2023). DOI: 10.1089/ind.2023.0009

A new comprehensive review published in Industrial Biotechnology examines how industrial biotechnology and biopharmaceutical manufacturing utilize the same framework for efficient biochemical production, which can be leveraged in current and future collaborations to enable rapid innovation.

In the article titled "Cells as Biofactories: Parallels Between Biopharmaceutical Manufacturing and Industrial Biotechnology," Lauren Cordova and Kelvin Lee, from the University of Delaware, describe advances in , , including CRISPR and sequencing technologies, and strain/clone development, and , that have contributed to rapid progress in new product development and innovation in both biopharmaceutical manufacturing and industrial biotechnology.

The authors discuss mechanisms for cross-disciplinary innovation and point to consortia groups that have been created to promote and further develop technology.

"With additional collaboration through these groups and new partnerships, future innovation can bridge industrial biotechnology and biopharmaceutical manufacturing to more rapidly engineer cells as efficient biofactories," state the authors.

"Cordova and Lee raise important points about the commonalities of tools and techniques that are used in industrial biotechnology and biopharmaceutical manufacturing. Indeed, scientific and engineering communities engaged in these activities are highly fragmented. This is revealed by specialized sessions at meetings and identification of scientists/engineers as working in either or biopharmaceutical manufacturing" says Editor-in-Chief Richard A. Gross, Ph.D.

More information: Lauren Cordova et al, Cells as Biofactories: Parallels Between Biopharmaceutical Manufacturing and Industrial Biotechnology, Industrial Biotechnology (2023). DOI: 10.1089/ind.2023.0009
www.liebertpub.com/doi/10.1089/ind.2023.0009

Citation: Advancing technologies for using cells as biofactories (2023, September 27) retrieved 17 June 2024 from https://phys.org/news/2023-09-advancing-technologies-cells-biofactories.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Biotechnology platforms enable fast, customizable vaccine production

7 shares

Feedback to editors